- $34.28bn
- $35.42bn
- $5.91bn
- 99
- 17
- 86
- 74
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 4,245 | 4,099 | 4,734 | 5,476 | 5,907 |
Cost of Revenue | |||||
Gross Profit | 2,695 | 2,754 | 3,290 | 3,782 | 4,004 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 3,877 | 3,654 | 3,818 | 4,376 | 4,670 |
Operating Profit | 368 | 445 | 916 | 1,100 | 1,237 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 276 | 326 | 970 | 1,027 | 1,147 |
Provision for Income Taxes | |||||
Net Income After Taxes | 233 | 267 | 794 | 808 | 882 |
Net Income Before Extraordinary Items | |||||
Net Income | 233 | 267 | 794 | 808 | 882 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 233 | 267 | 794 | 808 | 882 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 2.67 | 3.43 | 9.27 | 10.6 | 10.1 |